Historical record - last NADAC effective date: 12/17/2014
Product Information
CLARITIN 5 MG REDITABS is a brand product labeled by Bayer HealthCare LLC, priced at $0.6881 per EA under NDC 11523720201. Its NADAC has been published 58 times since Nov 28, 2013.
FDA first approved this application on Dec 12, 2006.
The High Outlier badge above means this manufacturer's average price in the Loratadine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Bayer HealthCare LLCNDC
11523720201
Classification
Brand
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
12/17/2014
Active Ingredients
LORATADINEApproval Type
New Drug (NDA)
FDA Application
NDA021993FDA Approved
12/12/2006
On Market Since
12/12/2006
Price Statistics
The NADAC for CLARITIN 5 MG REDITABS has been published 58 times since Nov 28, 2013, and over the history we have for it it has declined 5.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6881 per EA |
|---|---|
| All-time high | $0.7566 (Jul 16, 2014) |
| All-time low | $0.6602 (Jul 23, 2014) |
| Median price | $0.6950 |
| Average price | $0.6931 |
| Largest weekly change | -12.7% (Jul 23, 2014) |
| Weeks tracked | 58 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-5.6%
Last surveyed Dec 31, 2014 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 41% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bayer HealthCare LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Loratadine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLARITIN 5 MG REDITABS?
The current National Average Drug Acquisition Cost (NADAC) for CLARITIN 5 MG REDITABS, manufactured by Bayer HealthCare LLC, is $0.6881 per EA (NDC 11523720201), effective Dec 31, 2014.
How has the price of CLARITIN 5 MG REDITABS changed over time?
Over the history we have for it, the NADAC for CLARITIN 5 MG REDITABS has declined 5.6%. It has been tracked across 58 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLARITIN 5 MG REDITABS?
Since Nov 28, 2013, the NADAC for CLARITIN 5 MG REDITABS has ranged from a low of $0.6602 (Jul 23, 2014) to a high of $0.7566 (Jul 16, 2014), with a median of $0.6950 per EA.
Are there cheaper alternatives to CLARITIN 5 MG REDITABS?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CHILD LORATADINE 5 MG TAB CHEW, is $0.4040 per EA — about 41% below CLARITIN 5 MG REDITABS.
Who manufactures CLARITIN 5 MG REDITABS?
CLARITIN 5 MG REDITABS (NDC 11523720201) is labeled by Bayer HealthCare LLC, and CMS classifies it as a brand product.